Showing results (141-150 of 844) with videos related to

Sort By:
Pageof 85
Dementia and Geriatric Cognitive Disorders|February 28, 2009
Cardiovascular disease risk factors and progression of Alzheimer's diseaseGabor Abellan van Kan, Yves Rolland, Fati Nourhashémi, et al.
Drugs & Aging|March 21, 2013
Persistent use of analgesic medications in mild-to-moderate Alzheimer's diseaseAdeline Gallini, Virginie Gardette, Bruno Vellas, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|October 17, 2014
Sarcopenia-related parameters and incident disability in older persons: results from the "invecchiare in Chianti" studyMatteo Cesari, Yves Rolland, Gabor Abellan Van Kan, et al.
BMC Public Health|September 19, 2013
Incidence and economical effects of pneumonia in the older population living in French nursing homes: design and methods of the INCUR studyLaurent Demougeot, Yves Rolland, Stéphane Gérard, et al.
Internal and Emergency Medicine|September 21, 2021
Predictors of drug prescription in nursing home residents: results from the INCUR studyLaura Calcaterra, Marco Proietti, Edoardo Saporiti, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 20, 2019
Estimated Glomerular Filtration Rate Decline and Incident Frailty in Older AdultsFlorent Guerville, Philipe de Souto Barreto, Benjamin Taton, et al.
Experimental Gerontology|January 15, 2018
Chronic inflammation and sarcopenia: A regenerative cell therapy perspectiveJagadish K Chhetri, Philipe de Souto Barreto, Bertrand Fougère, et al.
Epidemiologic Reviews|September 10, 2008
Dementia prevention: methodological explanations for inconsistent resultsNicola Coley, Sandrine Andrieu, Virginie Gardette, et al.
Clinics in Geriatric Medicine|May 26, 2010
The assessment of frailty in older adultsGabor Abellan van Kan, Yves Rolland, Mathieu Houles, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 16, 2012
Exploring the relationship between Alzheimer's disease severity and longitudinal costsThomas Rapp, Sandrine Andrieu, Laurent Molinier, et al.
Pageof 85